Coated pellets with delayed-release glucose for prevention of hypoglycemic episodes

1. European Medicines Agency: Committee for Medicinal Products for Human Use, Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus, Rev 1, 2012; http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129256.pdf; access date May 25, 2015.Search in Google Scholar

2. E. R. Seaquist, J. Anderson, B. Childs, P. Cryer, S. Dagogo-Jack, L. Fish, S. R. Heller, H. Rodriguez, J. Rosenzweig and R. Vigersky, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society Diabetes Care, Diabetes Care36 (2013) 1384–1395; DOI: 10.2337/dc12-2480.10.2337/dc12-2480Search in Google Scholar

3. V. J. Briscoe and S. N. Davis, Hypoglycemia in type 1 and type 2 diabetes: Physiology, Pathophysiology, and Management, Clin. Diabetes24 (2006) 115–121; DOI: 10.2337/diaclin.24.3.115.10.2337/diaclin.24.3.115Search in Google Scholar

4. C. Kenny, When hypoglycemia is not obvious: Diagnosing and treating under-recognized and undisclosed hypoglycemia, Prim. Care Diabetes8 (2014) 3–11; DOI: 10.1016/j.pcd.2013.09.002.10.1016/j.pcd.2013.09.002Search in Google Scholar

5. C. Ryan, N. Gurtunca and D. Becker, Hypoglycemia: A complication of diabetes therapy in children, Pediatr. Clin. North Am.52 (2005) 1705–1733.10.1016/j.pcl.2005.08.002Search in Google Scholar

6. A. Franc, J. Muselík, D. Sabadková and D. Neumann, Preparation of pellets with controlled release of glucose as prevention of hypoglycaemia in paediatric patients, Eur. J. Pharm. Sci.75 (2015) 72–80; DOI: 10.1016/j.ejps.2015.03.007.10.1016/j.ejps.2015.03.007Search in Google Scholar

7. European Pharmacopoeia, 8^th edition, Council of Europe, Strasbourg 2013.Search in Google Scholar

8. M. Rabišková, Technological parameters of drug microforms, their importance and the methods of their determination, Ceska Slov. Farm.45 (1996) 177–179.Search in Google Scholar

9. F. Podczeck, S. R. Rahman and J. M. Newton, Evaluation of a standardised procedure to assess the shape of pellets using image analysis, Int. J. Pharm.192 (199) 123–138.10.1016/S0378-5173(99)00302-6Search in Google Scholar

10. R. Chopra, F. Podczeck, J. M. Newton and G. Alderborn, The influence of pellet shape and film coating on the filling of pellets into hard shell capsules, Eur. J. Pharm. Biopharm.53 (2002) 327–333.10.1016/S0939-6411(02)00015-2Search in Google Scholar

11. C. T. Rhodes and S. C. Porter, Coatings for controlled-release drug delivery systems, Drug Dev. Ind. Pharm.24 (1998) 1139–1154.10.3109/03639049809108573Search in Google Scholar

12. H. U. Petereit and W. Weisbrod, Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers, Eur. J. Pharm. Biopharm.47 (1999) 15–25.10.1016/S0939-6411(98)00083-6Search in Google Scholar

13. J. Vertomrnen and R. Kinget, The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor, Drug Dev. Ind. Pharm.23 (1997) 39–46.10.3109/03639049709148480Search in Google Scholar

14. J. Muselík, K. Dvořáčková, K. Krejčová, M. Rabišková, J. Pazourek, S. Marton, M. Dráčková and L. Vorlová, Pellet coating thickness determination by near-infrared reflectance spectroscopy: comparison of two reference methods, Curr. Pharm. Anal.6 (2010) 225–233; DOI: 10.2174/157341210793292419.10.2174/157341210793292419Search in Google Scholar

15. L. A. Felton and J. W. McGinity, Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, 3^rd edition, CMC Press, Boca Raton 2008.10.3109/9780849387883Search in Google Scholar

16. F. Sadeghi, J. L. Ford and A. Rajabi-Siahboomi, The influence of drug type on the release profiles from Surelease-coated pellets, Int. J. Pharm.254 (2003) 123–135; DOI: 10.1016/S0378-5173(03)00003-6.10.1016/S0378-5173(03)00003-6Search in Google Scholar

17. J. J. Soisa, A. Sousa, M. J. Moira, F. Podczeck and J. M. Newton, The influence of core materials and film coating on the drug release from coated pellets, Int. J. Pharm.233 (2002) 111–122; DOI: 10.1016/S0378-5173(01)00921-8.10.1016/S0378-5173(01)00921-8Search in Google Scholar

18. A. Franc, K. Dvořáčková, M. Kejdušová and R. Goněc, Physiological factors with impact on the drug behaviour in the gastrointestinal tract, Ceska Slov. Farm.62 (2013) 243−248.Search in Google Scholar

19. S. Milojevic, J. M. Newton, J. H. Cummings, G. R. Gibson, R. L. Botham, S. G. Ring, M. Stockham and M. C. Alwood, Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets, J. Control. Release38 (1996) 85−94; DOI: 10.1016/0168-3659(95)00113-1.10.1016/0168-3659(95)00113-1Search in Google Scholar

20. J. Rojas, S. Guisao and V. Ruge, Functional assessment of four types of disintegrants and their effect on the spironolactone release properties, AAPS PharmSciTech.13 (2012) 1054–1062; DOI: 10.1208/s12249-012-9835-y.10.1208/s12249-012-9835-y351345922899380Search in Google Scholar

21. M. Rabišková, A. Häring, K. Minczingerová, M. Havlásek and P. Musilová, Microcrystalline cellulose in oral dosage forms, Chem. Listy101 (2007) 70−77.Search in Google Scholar

22. A. Franc, D. Sabadková, D. Neumann, S. Pavloková, Kopecká and P. J. Muselík, Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release, Pharm. Dev. Technol.3 (2015) 1–8.Search in Google Scholar